Summary: The Centers for Medicare & Medicaid Services modified its HIV Testing (Prognosis Including Monitoring) coverage policy, effective May 15, 2026. Here's what billing teams need to do.
CMS HIV testing coverage policy changes don't happen often, but when they do, the downstream billing effects are wide. This modification covers HIV testing for prognosis and ongoing monitoring — not just initial diagnosis. The policy does not list specific codes in the available documentation, so your team should pull the full policy text directly from CMS before May 15, 2026 and reconcile it against your current charge capture.
| Field | Detail |
|---|---|
| Payer | Centers for Medicare & Medicaid Services (CMS) |
| Policy | Human Immunodeficiency Virus (HIV) Testing (Prognosis Including Monitoring) |
| Policy Code | N/A |
| Change Type | Modified |
| Effective Date | May 15, 2026 |
| Impact Level | High |
| Specialties Affected | Infectious disease, internal medicine, primary care, HIV specialty clinics, clinical laboratories |
| Key Action | Review your HIV monitoring test billing workflows and confirm documentation supports medical necessity for prognosis and monitoring indications before May 15, 2026 |
CMS HIV Testing Coverage Criteria and Medical Necessity Requirements 2026
The CMS HIV testing coverage policy covers two distinct clinical functions: prognosis and ongoing monitoring. These are not the same as diagnostic testing for new HIV infections. If your billing team has been treating all HIV-related testing under a single workflow, this distinction is the first thing to fix.
Medical necessity documentation is everything here. CMS requires that claims for HIV monitoring tests reflect a clinical rationale tied to the patient's HIV status and treatment trajectory. A CD4 count ordered to monitor disease progression in a confirmed HIV-positive patient is a different claim than a screening test ordered for an at-risk individual. Your documentation needs to make that distinction clear.
Prior authorization requirements for HIV monitoring tests vary by Medicare Advantage plan. If your patients are in MA plans, don't assume the CMS fee-for-service rules apply directly. Check each plan's prior auth requirements separately.
The real issue with this type of coverage policy modification is that "prognosis" and "monitoring" are clinical categories that depend heavily on how the ordering provider documents intent. A lab can run the test, but if the ordering note doesn't reflect the monitoring context, you're exposed to claim denial. Train your ordering providers alongside your billing team — this is a joint documentation problem, not just a coding problem.
Medical necessity criteria for HIV monitoring typically center on the patient's confirmed HIV-positive status, current antiretroviral therapy (ART) status, and clinical indicators such as viral load trajectory, CD4 cell count trends, and evidence of treatment response or failure. When CMS reviews these claims, they're looking for that clinical thread in the documentation. Make sure it's there.
CMS HIV Testing Exclusions and Non-Covered Indications
The available policy documentation does not include a specific exclusions list. However, based on the policy scope — prognosis and monitoring — testing ordered outside of an established HIV diagnosis context is unlikely to qualify under this policy.
Routine HIV screening for individuals without a confirmed diagnosis falls under different coverage authority, including the USPSTF-aligned preventive services benefit. Don't bill screening tests under a monitoring indication. CMS distinguishes between these categories, and mixing them up is a fast path to claim denial.
Testing ordered without documentation of a treating relationship with an HIV-positive patient is another high-risk scenario. If the ordering provider isn't actively managing the patient's HIV care, the medical necessity argument weakens significantly.
Coverage Indications at a Glance
The policy documentation available does not include a coded indication-by-indication coverage table. The table below reflects the policy's stated scope based on the title and clinical context of this coverage policy type.
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| HIV viral load monitoring in confirmed HIV-positive patients | Covered (when medically necessary) | Not listed in available data | Must document treatment context and clinical rationale |
| CD4 cell count monitoring for HIV prognosis | Covered (when medically necessary) | Not listed in available data | Frequency limitations may apply — check MAC LCDs |
| HIV monitoring during ART | Covered (when medically necessary) | Not listed in available data | Document ART regimen and clinical response in the record |
| HIV screening for at-risk individuals (no confirmed diagnosis) | Not covered under this policy | Not listed in available data | Bill under preventive services — separate coverage authority |
| HIV testing without documented monitoring or prognosis rationale | Not covered | Not listed in available data | Lack of documentation = claim denial risk |
If your Medicare Administrative Contractor (MAC) has issued a local coverage determination (LCD) that intersects with this policy, the LCD controls. Pull your MAC's current HIV testing LCD and reconcile it against this CMS modification before May 15, 2026.
CMS HIV Testing Billing Guidelines and Action Items 2026
The effective date of May 15, 2026 gives your team a defined deadline. Use it.
| # | Action Item |
|---|---|
| 1 | Pull the full policy text from CMS. The available documentation for this modification does not include specific CPT or HCPCS codes. Go to the CMS source directly at the official policy page and get the complete version. Don't build your workflow on incomplete data. |
| 2 | Check your MAC's LCD for HIV testing. This CMS modification sits alongside local coverage determinations from your MAC. Local LCDs often add frequency limits, documentation requirements, and code-level specificity that the national policy doesn't include. If you're not sure which MAC covers your jurisdiction, look it up now — before May 15, 2026. |
| 3 | Audit your documentation templates for HIV monitoring visits. Your ordering providers' notes need to document the specific clinical rationale for each monitoring test — viral load trajectory, CD4 trend, ART response. Generic "HIV follow-up" notes won't support a claim denial challenge. Update your EHR templates to prompt providers for this detail. |
| 4 | Separate your monitoring and screening workflows. If your practice bills both HIV screening and HIV monitoring, these need to be two distinct workflows with separate documentation requirements and code sets. Conflating them creates medical necessity exposure on both sides. |
| 5 | Review prior authorization requirements for Medicare Advantage patients. CMS HIV testing reimbursement rules for traditional Medicare don't automatically apply to MA plans. Pull the PA requirements for your top five MA payers and update your prior auth checklist before the effective date. |
| 6 | Train your billing team on the prognosis vs. monitoring distinction. This isn't a subtle difference. Prognosis testing helps establish disease staging and expected trajectory. Monitoring testing tracks response to treatment over time. If your coders can't articulate the difference, they can't catch documentation gaps before claims go out. |
| 7 | If your practice has high HIV testing volume, loop in your compliance officer. This coverage policy modification may intersect with your current billing patterns in ways that aren't immediately obvious. A compliance review before May 15, 2026 is cheaper than a post-payment audit. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for HIV Testing (Prognosis Including Monitoring) Under This Policy
The policy data available for this modification does not include a specific list of CPT, HCPCS, or ICD-10 codes. This is a critical gap.
Do not construct your billing workflow from general knowledge of HIV testing codes alone. The specific codes covered — and any codes with changed coverage status — must come from the full CMS policy document and your MAC's LCD.
What to Do Instead of Assuming Codes
Pull the complete policy document from CMS. Cross-reference it against your MAC's HIV testing LCD. Build your code list from those two sources together.
Common HIV testing code categories that may be addressed in the full policy include viral load quantification, CD4/CD8 lymphocyte counts, HIV genotypic resistance testing, and HIV drug susceptibility testing. But the specific codes, coverage conditions, and any frequency limitations must come from the official source — not from this summary.
If you need help mapping codes to this policy, your MAC's provider relations line is a direct resource. Use it.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.